Is HLA-DQ2 useful for blood sugar?

HLA-DQ2 is an immune system gene primarily associated with celiac disease. It has no direct, clinically relevant role in blood sugar regulation. Therefore, a DNA test for HLA-DQ2 cannot be used to assess blood glucose levels or diabetes risk. Indirectly, untreated celiac disease may impair nutrient absorption and affect blood sugar, but this is a specific medical condition, not a general biomarker. The evidence for using HLA-DQ2 in a blood sugar context is weak, based on mechanistic reasoning rather than validated studies. Consumers should not rely on such genetic tests for blood sugar management. Established methods like fasting glucose, HbA1c, and oral glucose tolerance tests, along with lifestyle factors, remain the standard.